The FDA has approved a new Pfizer meningococcal vaccine whose simpler dosing schedule is expected to make it easier for children and young adults to get fully vaccinated to protect against a rare ...

A college student has died and two people are being treated after cases of meningitis in Reading, Berkshire, the UK Health ...

The ACIP voted that Penmenvy may be used as part of the adolescent meningococcal vaccination schedule as an alternative to separate administration of MenACWY and MenB. The Centers for Disease Control ...

The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug Administration ...

Add Yahoo as a preferred source to see more of our stories on Google. A new vaccine from Pfizer has been approved by the Food and Drug Administration as the first shot of its kind to address multiple ...

The US Food and Drug Administration has approved a meningococcal vaccine against the five most common serogroups causing disease in children and young adults. The new formulation called Penbraya is ...

The government will fund a $9 million program to vaccinate students against meningococcal B from January 1 next year.

During its September 2024 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the go-ahead for Penbraya (Pfizer) — meningococcal groups A, C, W, Y ...

Patti Wukovits still thinks about how she had to bury her daughter in her prom dress. In June 2012, 17-year-old Kimberly Coffey had a fever and body aches. She told her mom it felt like her ankles ...

GSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization Practices (“ACIP”) voted favorably, recommending the use of Penmenvy ...

Invasive meningococcal disease caused by Neisseria meningitidis is primarily associated with serogroups A, B, C, W, X, and Y and is characterised by its sudden, unpredictable nature and devastating ...

A life-saving Meningococcal B vaccination program will be delivered as part of the 2026-27 Budget to help protect Tasmanians from this serious but preventable disease, while easing cost-of-living ...